The Epstein–Barr virus nuclear antigen 2 is one of the six EBV viral nuclear proteins expressed in latently infected B lymphocytes is a transactivator protein. From Wikipedia
Research reveals how EBV hijacks immune cell migration to spread systemically, with new inhibitors showing promise in preclinical models.
